skip to content
Primary navigation

Lupaneta Pack

Drug - Lupaneta Pack™ (leuprolide for injection and norethindrone tablets for oral administration) [AbbVie Inc.]

June 2016

Therapeutic area - Endometriosis

Approval criteria

  • Patient must have a diagnosis of endometriosis AND
  • Provider must provide a very compelling reason as to why Lupaneta Pack is required

Therapy limitations

Initial course of treatment will be limited to 6 months with maximum therapy limited to 1 year, due to the potential of adverse impact on bone density.


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top